Cargando…

R and nlmixr as a gateway between statistics and pharmacometrics

Detalles Bibliográficos
Autores principales:	Fidler, Matthew, Hooijmaijers, Richard, Schoemaker, Rik, Wilkins, Justin J., Xiong, Yuan, Wang, Wenping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099435/ https://www.ncbi.nlm.nih.gov/pubmed/33951757 http://dx.doi.org/10.1002/psp4.12618

Ejemplares similares

Nonlinear Mixed‐Effects Model Development and Simulation Using nlmixr and Related R Open‐Source Packages
por: Fidler, Matthew, et al.
Publicado: (2019)

Performance of the SAEM and FOCEI Algorithms in the Open‐Source, Nonlinear Mixed Effect Modeling Tool nlmixr
por: Schoemaker, Rik, et al.
Publicado: (2019)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

Time to Expect More From Pharmacometrics
por: Barrett, Jeffrey S.
Publicado: (2020)

Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
por: Ding, Junjie, et al.
Publicado: (2020)

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
por: Chaturvedula, Ayyappa, et al.
Publicado: (2019)

Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Variable or variate? A conundrum in pharmacometrics exposure–response models
por: Grisic, Ana‐Marija, et al.
Publicado: (2022)

Barriers to global pharmacometrics: educational challenges and opportunities across the globe
por: Michelet, Robin, et al.
Publicado: (2023)

Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction
por: Craig, M, et al.
Publicado: (2016)

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

The Mathematical and Computational Sciences Special Interest Group of the International Society of Pharmacometrics
por: Moore, Helen
Publicado: (2019)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
por: Hennig, Stefanie, et al.
Publicado: (2019)

The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities
por: Kaibara, Atsunori, et al.
Publicado: (2022)

Welcome to the statistics and pharmacometrics themed issue
por: French, Jonathan, et al.
Publicado: (2021)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019)

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)
por: Sinha, Vikram, et al.
Publicado: (2021)

Global gateways as telecoupled human and natural systems: The emerging case of the Bering Strait
por: Waloven, Sydney, et al.
Publicado: (2023)

Nicotine-induced dopamine plasticity: a gateway to neurotransmitter replacement?
por: Lai, I-Chi, et al.
Publicado: (2019)

Proapoptotic RECS1: a requisite gateway to lysosomal dysfunction and death
por: Pihán, Philippe, et al.
Publicado: (2022)

Goat lactation research as a gateway for the development of the dairy goat industry
por: Castro, Noemí, et al.
Publicado: (2023)

Pharmacometrics meets statistics—A synergy for modern drug development
por: Ryeznik, Yevgen, et al.
Publicado: (2021)

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking
por: Hall, Wayne, et al.
Publicado: (2021)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members
por: Mentré, F, et al.
Publicado: (2013)

Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence
por: Frey, Nicolas, et al.
Publicado: (2021)

Interactive Pharmacometric Applications Using R and the Shiny Package
por: Wojciechowski, J, et al.
Publicado: (2015)

Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012)

Pharmacometric models simulation using NONMEM, Berkeley Madonna and R
por: Park, Wan-Su
Publicado: (2017)

CPT: Pharmacometrics and Systems Pharmacology
por: van der Graaf, Piet H
Publicado: (2012)

Pharmacometric Characterization of Dabigatran Hemodialysis
por: Liesenfeld, Karl-Heinz, et al.
Publicado: (2013)

CPT: Pharmacometrics & Systems Pharmacology
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vaditv232gajtentndt2273bkl